Epigenetic regulation of the neuroblastoma genes, Arid3b and Mycn

Oncogene

Volumn 32, Issue 21, 2013, Pages 2640-2648

  Kobayashi, K ^a   Jakt, L M ^a   Nishikawa, S I ^a  

^a RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

Arid3b; embryonic stems cell; epigenetics; molecular network for pluripotency; Mycn; neuroblastoma

Indexed keywords

AT RICH ITERACTION DOMAIN MOLECULE 3B PROTEIN; HISTONE; MYC PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE PROGRESSION; CELL DEATH; CELL PROLIFERATION; CELL TYPE; EMBRYONIC STEM CELL; EPIGENETICS; GENE EXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN CELL; NEURAL CREST; NEUROBLASTOMA; PRIORITY JOURNAL; SOMATIC CELL; TESTIS;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA-BINDING PROTEINS; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GANGLIA, SYMPATHETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, TRANSGENIC; NEOPLASMS, GERM CELL AND EMBRYONAL; NEURAL CREST; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS;

IPS;

EID: 84878223532     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.285     Document Type: Article

References (34)

1. Numata S, Claudio PP, Dean C, Giordano A, Croce CM. Bdp a new member of a family of DNA-binding proteins, associates with the retinoblastoma gene product. Cancer Res 1999; 59: 3741-3747.
2. Takebe A, Era T, Okada M, Martin Jakt L, Kuroda Y, Nishikawa S. Microarray analysis of PDGFR alpha populations in ES cell differentiation culture identifies genes involved in differentiation of mesoderm and mesenchyme including ARID3b that is essential for development of embryonic mesenchymal cells. Dev Biol 2006; 293: 25-37.
3. Kobayashi K, Era T, Takebe A, Jakt LM, Nishikawa S. ARID3B induces malignant transformation of mouse embryonic fibroblasts and is strongly associated with malignant neuroblastoma. Cancer Res 2006; 66: 8331-8336.
4. Sawai S, Shimono A, Wakamatsu Y, Palmes C, Hanaoka K, Kondoh H. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development 1993; 117: 1445-1455.
5. Kim J, Chu J, Shen X, Wang J, Orkin SH. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008; 132: 1049-1061.
6. Kidder BL, Yang J, Palmer S. Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells. PLoS One 2008; 3: e3932.
7. Kim J, Woo AJ, Chu J, Snow JW, Fujiwara Y, Kim CG et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 2010; 143: 313-324.
8. Larsson LG, Henriksson MA. The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy. Exp Cell Res 2010; 316: 1429-1437.
9. Li Z, Hann SR. The Myc-nucleophosmin-ARF network: a complex web unveiled. Cell Cycle 2009; 8: 2703-2707.
10. Cotter TG. Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 2009; 9: 501-507.
11. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999; 86: 364-372.
12. Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J et al. The ground state of embryonic stem cell self-renewal. Nature 2008; 453: 519-523.
13. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
14. Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW, Smith A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 2008; 6: e253.
15. Sridharan R, Tchieu J, Mason MJ, Yachechko R, Kuoy E, Horvath S et al. Role of the murine reprogramming factors in the induction of pluripotency. Cell 2009; 136: 364-377.
16. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008; 454: 49-55.
17. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003; 3: 203-216.
18. Nakagawara A. Neural crest development and neuroblastoma: the genetic and biological link. Prog Brain Res 2004; 146: 233-242.
19. Pardo M, Lang B, Yu L, Prosser H, Bradley A, Babu MM et al. An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 2010; 6: 382-395.
20. Varlakhanova NV, Cotterman RF, deVries WN, Morgan J, Donahue LR, Murray S et al. myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation 2010; 80: 9-19.
21. Smith KN, Singh AM, Dalton S. Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell 2010; 7: 343-354.
22. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 2005; 132: 885-896.
23. Maris JM, Denny CT. Focus on embryonal malignancies. Cancer Cell 2002; 2: 447-450.
24. Mosse YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 2008; 455: 930-935.
25. Aiden AP, Rivera MN, Rheinbay E, Ku M, Coffman EJ, Truong TT et al. Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network. Cell Stem Cell 2010; 6: 591-602.
26. Tada S, Era T, Furusawa C, Sakurai H, Nishikawa S, Kinoshita M et al. Characterization of mesendoderm: diverging point of the definitive endoderm and mesoderm in embryonic stem cell differentiation culture. Development 2005; 132: 4363-4374.
27. Reynolds BA, Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 1996; 175: 1-13.
28. Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M et al. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci USA 2011; 108: 14234-14239.
29. Wartiovaara K, Barnabe-Heider F, Miller FD, Kaplan DR. Mycn promotes survival and induces S-phase entry of postmitotic sympathetic neurons. J Neurosci 2002; 22: 815-824.
30. Nishishita N, Ijiri H, Takenaka C, Kobayashi K, Goto K, Kotani E et al. The use of leukemia inhibitory factor immobilized on virus-derived polyhedra to support the proliferation of mouse embryonic and induced pluripotent stem cells. Biomaterials 2011; 32: 3555-3563.
31. Yoshimizu T, Sugiyama N, De Felice M, Yeom YI, Ohbo K, Masuko K et al. Germline-specific expression of the Oct-4/green fluorescent protein (GFP) transgene in mice. Dev Growth Differ 1999; 41: 675-684.
32. Miyoshi H. Gene delivery to hematopoietic stem cells using lentiviral vectors. Methods Mol Biol 2004; 246: 429-438.
33. Guo G, Yang J, Nichols J, Hall JS, Eyres I, Mansfield W et al. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 2009; 136: 1063-1069.
34. Tachibana M, Matsumura Y, Fukuda M, Kimura H, Shinkai Y. G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. EMBO J 2008; 27: 2681-2690.